Research output: Contribution to journal › Article › peer-review
Comparative Evaluation of the Clinical Efficacy of PRP-Therapy, Minoxidil, and Their Combination with Immunohistochemical Study of the Dynamics of Cell Proliferation in the Treatment of Men with Androgenetic Alopecia. / Pakhomova, Elena E; Smirnova, Irina O.
In: International Journal of Molecular Sciences, Vol. 21, No. 18, 6516, 09.2020.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Comparative Evaluation of the Clinical Efficacy of PRP-Therapy, Minoxidil, and Their Combination with Immunohistochemical Study of the Dynamics of Cell Proliferation in the Treatment of Men with Androgenetic Alopecia
AU - Pakhomova, Elena E
AU - Smirnova, Irina O
PY - 2020/9
Y1 - 2020/9
N2 - Platelet-rich plasma (PRP) therapy has been considered as a promising treatment for androgenetic alopecia (AGA). The aim of the study was comparative evaluation of the clinical efficacy of PRP-therapy, minoxidil, and their combination in the treatment of men with AGA and to evaluate the effects of PRP on the proliferation of hair follicle (HF) cells in skin biopsy.MATERIALS AND METHODS: The study involved 69 men who were divided into 3 groups who received PRP therapy, minoxidil, and their combination. The clinical efficacy of the therapy was evaluated by the dynamics of morphometric of hairs. To assess cell proliferation antibodies to β-catenin, CD34, Ki67, and to Dkk-1 were used.RESULTS: PRP treatment was more effective than minoxidil therapy (p = 0.005). Complex therapy turned out to be more effective than minoxidil monotherapy (p < 0.0001) and PRP monotherapy (p = 0.007). After applying PRP the absolute and relative values of the β-catenin and CD34 expression area increased; an increase in Ki67+ index was also significant.CONCLUSIONS: PRP can be considered as a treatment option for AGA. Combined PRP and minoxidil use seems promising for the treatment of AGA. PRP increase in the proliferative activity of HF cells and improves hair morphology in patients with AGA.
AB - Platelet-rich plasma (PRP) therapy has been considered as a promising treatment for androgenetic alopecia (AGA). The aim of the study was comparative evaluation of the clinical efficacy of PRP-therapy, minoxidil, and their combination in the treatment of men with AGA and to evaluate the effects of PRP on the proliferation of hair follicle (HF) cells in skin biopsy.MATERIALS AND METHODS: The study involved 69 men who were divided into 3 groups who received PRP therapy, minoxidil, and their combination. The clinical efficacy of the therapy was evaluated by the dynamics of morphometric of hairs. To assess cell proliferation antibodies to β-catenin, CD34, Ki67, and to Dkk-1 were used.RESULTS: PRP treatment was more effective than minoxidil therapy (p = 0.005). Complex therapy turned out to be more effective than minoxidil monotherapy (p < 0.0001) and PRP monotherapy (p = 0.007). After applying PRP the absolute and relative values of the β-catenin and CD34 expression area increased; an increase in Ki67+ index was also significant.CONCLUSIONS: PRP can be considered as a treatment option for AGA. Combined PRP and minoxidil use seems promising for the treatment of AGA. PRP increase in the proliferative activity of HF cells and improves hair morphology in patients with AGA.
KW - Androgenetic alopecia (AGA)
KW - CD34
KW - Dkk-1
KW - Hair follicle cell proliferation
KW - Hair morphometry
KW - Ki67
KW - Minoxidil
KW - Platelet-rich plasma (PRP)
KW - β-catenin
KW - beta-catenin
KW - platelet-rich plasma (PRP)
KW - PLATELET-RICH PLASMA
KW - GROWTH-FACTORS
KW - androgenetic alopecia (AGA)
KW - hair follicle cell proliferation
KW - minoxidil
KW - hair morphometry
UR - http://www.scopus.com/inward/record.url?scp=85090221206&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/93236ef6-6f20-378f-bb5e-81e220bef916/
U2 - 10.3390/ijms21186516
DO - 10.3390/ijms21186516
M3 - Article
C2 - 32899959
VL - 21
JO - International Journal of Molecular Sciences
JF - International Journal of Molecular Sciences
SN - 1422-0067
IS - 18
M1 - 6516
ER -
ID: 72055055